Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-19 @ 1:42 AM
Study NCT ID:
NCT06709859
Status:
RECRUITING
Last Update Posted:
2025-07-17
First Post:
2024-11-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC
Sponsor:
Shandong Public Health Clinical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
GWLCZXEC2024-56-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None